NCT03548883View on ClinicalTrials.gov

Examining Neuroinflammation in AlzHeimer's

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 9, 2022

Study Completion Date

May 9, 2022

Conditions
Alzheimer Disease, Early-Onset
Sponsors

Lead Sponsor

AdventHealth
All Listed Sponsors
lead

AdventHealth

OTHER

NCT03548883 - Examining Neuroinflammation in AlzHeimer's | Biotech Hunter | Biotech Hunter